Is laser treatment effective for chemotherapy-related vaginal atrophy?
Laser treatment may offer some benefit for vaginal atrophy after chemotherapy, particularly when hormonal therapies are not an option, but the evidence remains limited and further research is needed.
Detailed Medical Explanation
Chemotherapy can induce premature menopause and lead to vaginal dryness and atrophy. For women who cannot use hormone replacement therapy (HRT), pilot studies show laser may improve symptoms like dryness, soreness, and dyspareunia, but robust, long-term evidence is lacking. Specialist assessment is essential to ensure safety and appropriateness. For more, see Macmillan Cancer Support and NICE guidance.
Clinical Context
Vaginal laser for post-chemotherapy atrophy should only be considered in a multi-disciplinary setting after full discussion of options and risks.
Evidence-Based Approaches
Current guidelines emphasise caution and recommend individualised decision-making, with laser reserved for selected women who have not benefited from standard care. See NICE guidance.